News Medical on MSN3d
Expanding access to anti-obesity medications delivers 13% return on investment for societyA new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...
A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...
State lawmakers are considering expanding the types of obesity treatments covered by Nevada Medicaid, including approving ...
Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...
Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...
A new University of Michigan study shows that a strong majority of older Americans want health insurance — including Medicare — to cover weight loss medica ...
Dr Harriet Treacy, co-founder of Beyondbmi, spoke with EVOKE to explain that obesity is a disease that requires medical treatment, whereas many people are simply availing of the drugs to lose a few ...
India Today on MSN13d
Mounjaro, popular weight-loss drug, launched in India. Here's how much it costsPopular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...
A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback